ClinicalTrials.gov
public full text
Public Domain
S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy
The purposes of the study were to obtain further information about the optimal dose and the efficacy of Keppra in daily clinical practice, and to confirm the favorable safety and tolerability profiles of the drug observed during clinical development.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of Cannabidiol for Drug-Resistant Epilepsies#915304
- Crossover, Single Dose Randomized, Bioequivalence of Ketoprofen Lysine Salt Immediate Release vs Oral Solution#827541
- University of Alabama at Birmingham (UAB) Adult CBD Program#828277
- Ketamine Treatment of Youth Suicide Attempters#906292
- The Pharmacokinetics of Cannabidiol (CBD) and Its Effects in Children With Severe Epilepsy#802846
Record · ID 991835
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive